Korea Yamanouchi Operational in 1995

Korea Yamanouchi, the joint-venture company set up by Japanese pharmaceutical company Yamanouchi and South Korean company Je Il Pharm, should be fully operational in the first half of 1995.

The company was set up in July with an investment of 4 billion won ($5 million) and will supply the Korean market with drugs developed by Yamanouchi.

- French pharmaceutical company Synthelabo has indicated that it wishes to increase sales in Japan through agreements with local companies, says Pharma Japan. The company has several agreements with local firms, including licensing agreements. Sales of Synthelabo products in Japan amount to around $200 million, or $300 million if sales through licensees are taken into account. Licensees include Mitsui, Sumitomo, Daiichi and Japan Medical Supply.